06:50 AM EDT, 08/12/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) reported a Q2 net loss Monday of $33.8 million, compared with its $18.9 million loss a year earlier.

Analysts polled by Capital IQ expected a loss of $35.2 million.

As of June 30, the company had $789.6 million in cash, cash equivalents and marketable securities, which it expects will enable it to fund its current operating expenses into Q1 2028.

Shares of Apogee were up more than 3% during recent premarket activity Monday.

Price: 41.99, Change: +1.49, Percent Change: +3.68